Together with UBE2C, it activates AKT/mTOR signaling pathway to increase the cell cycle progression, proliferation rate, cell survival, as well as the migratory and invasive abilities of ccRCC cells51. Here, MTOR is linked to nonpapillary renal cell carcinoma.